Skip to main content
Equibles

PURA VIDA INVESTMENTS, LLC

Position in NTRA — Natera, Inc.

CIK 1590144 NEW YORK, NY
Back to NTRA Full portfolio

Position in NTRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$407,175
-$92,800 QoQ
Shares Held
1,500
-40.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#566
of 847 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Dec 31, 2024
CallValue
$1,583,000
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PURA VIDA INVESTMENTS, LLC holds $3,267,760 across 2 Diagnostics & Research names. NTRA ranks #2 (12.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMDX
Insight Molecular Diagnostics Inc.
 484,845 $2,860,585
2 NTRA
Natera, Inc.
This page 		1,500 $407,175

All Filings in NTRA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $407,175 1,500
2026-03-31 $499,975 2,500
2025-12-31 $572,725 2,500
2025-09-30 $402,425 2,500
2025-06-30 $422,350 245,691
2025-03-31 $353,525 2,500
2024-12-31 $1,583,000 10,000
2024-12-31 $791,500 5,000
2024-09-30 $5,522,325 43,500
2024-06-30 $7,309,575 67,500
2024-03-31 $6,549,084 71,606
2023-12-31 $5,825,520 93,000
2023-12-31 $3,019,248 48,200
2023-09-30 $10,979,796 248,131
2023-06-30 $9,736,574 200,094
2023-03-31 $13,126,593 236,430
2022-12-31 $6,628,050 165,000
2022-06-30 $2,132,034 60,159
2021-12-31 $21,965,234 235,199
2021-09-30 $26,822,827 240,693
2021-06-30 $24,615,120 216,816
2021-03-31 $25,145,771 247,644
2020-12-31 $20,152,800 202,500
2020-09-30 $13,725,600 190,000